MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.carrev.2022.03.016

Медицинская библиотека · Cardiovascular revascularization medicine : including molecular interventions · 2022

Transcatheter Closure of Large Atrial Septal Defects in Adults.

Malzahn Lena, Bertog Stefan, Sievert Kolja, Reinhartz Markus, Schnelle Nalan, Grunwald Iris, Franke Jennifer, Gafoor Sameer A, Jovanovic Bojan, Vogel Anja, Ilioska-Damkoehler Pamela, Galeru Natalia, Sievert Horst

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To examine the outcomes of percutaneous closure of large atrial septal defects (ASDs) (≥25 mm).

BACKGROUND

Data on long-term results after closure of large ASDs are limited.

METHODS

We reviewed the records of 275 consecutive patients who underwent transcatheter closure of large (≥25 mm) ASDs from January 1999 until December 2016 in our center. The most common indication for closure was a large left-to-right shunt. Follow-up (FU) was performed at regular intervals thereafter. Results after closure of ASDs with diameters of 25-30 mm, >30-35 mm and >35 mm were compared.

RESULTS

Percutaneous closure was technically successful in 99.6%. Mean FU time was 4.8 years (0-15.5 years). Peri-operative (30-day) adverse events occurred in 20.4% and included death in 0.7% (one unrelated to the procedure and one of unknown cause), device erosion in 0.7%, device embolization in 2.9%, pericardial effusion in 5.5%, air embolism in 0.4%, new onset atrial fibrillation in 10.5%, transient supraventricular tachycardia in 0.4% and fever in 0.7%. Late (>30 days after the procedure) atrial fibrillation occurred in 5.8%. There was one device erosion >15 years after the implantation treated successfully surgically. Complete defect closure was achieved in 95.6%.

CONCLUSION

Device closure of large ASDs is feasible, safe and effective with high technical success and low risk of serious periprocedural complications. Nevertheless, in very large defects (>40 mm), both options, surgery and percutaneous closure should be considered. Device or procedural long-term adverse events are rare.

Для цитирования: Malzahn Lena, Bertog Stefan, Sievert Kolja, Reinhartz Markus, Schnelle Nalan, Grunwald Iris, Franke Jennifer, Gafoor Sameer A, Jovanovic Bojan, Vogel Anja, Ilioska-Damkoehler Pamela, Galeru Natalia, Sievert Horst. Transcatheter Closure of Large Atrial Septal Defects in Adults.. Cardiovascular revascularization medicine : including molecular interventions. 2022. DOI: 10.1016/j.carrev.2022.03.016.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.